Lanean...
Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients
BACKGROUND: Fluoroquinolones (FQs) are potential drugs that inhibit DNA synthesis and are used in the treatment of multidrug-resistant tuberculosis (TB) and short-term anti-TB regimens. In recent years, a high proportion of FQ resistance has been observed in Mycobacterium tuberculosis isolates. The...
Gorde:
| Argitaratua izan da: | BMC Pulm Med |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7216623/ https://ncbi.nlm.nih.gov/pubmed/32393213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-020-1172-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|